Integrative knowledge management to enhance pharmaceutical R&D

被引:9
|
作者
Marti-Solano, Maria [1 ,2 ]
Birney, Ewan [3 ]
Bril, Antoine [4 ]
Della Pasqua, Oscar [5 ]
Kitano, Hiroaki [6 ,7 ]
Mons, Barend [8 ,9 ]
Xenarios, Ioannis [10 ]
Sanz, Ferran [1 ,2 ]
机构
[1] IMIM, Barcelona 08003, Spain
[2] Univ Pompeu Fabra, Barcelona 08003, Spain
[3] European Bioinformat Inst, European Mol Biol Lab, Hinxton CB10 1SD, Cambs, England
[4] Inst Rech Int Servier, F-92284 Suresnes, France
[5] GlaxoSmithKline, Uxbridge UB11 1BT, Middx, England
[6] Syst Biol Inst, Minato Ku, Tokyo 1080071, Japan
[7] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan
[8] Netherlands Bioinformat Ctr, NL-6500 HB Nijmegen, Netherlands
[9] Leiden Univ, Med Ctr, NL-2333 ZA Leiden, Netherlands
[10] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland
关键词
HEALTH-CARE;
D O I
10.1038/nrd4290
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Information technologies already have a key role in pharmaceutical research and development (R&D), but achieving substantial advances in their use and effectiveness will depend on overcoming current challenges in sharing, integrating and jointly analysing the range of data generated at different stages of the R&D process. © 2014 Macmillan Publishers Limited. All rights reserved An.
引用
收藏
页码:239 / 240
页数:2
相关论文
共 50 条
  • [1] Integrative knowledge management to enhance pharmaceutical R&D
    Maria Marti-Solano
    Ewan Birney
    Antoine Bril
    Oscar Della Pasqua
    Hiroaki Kitano
    Barend Mons
    Ioannis Xenarios
    Ferran Sanz
    [J]. Nature Reviews Drug Discovery, 2014, 13 : 239 - 240
  • [2] Enhancing knowledge management for R&D innovation and firm performance: An integrative view
    Liao, Chechen
    Wang, Hsiu-Yu
    Chuang, Shu-Hui
    Shih, Meng-Lin
    Liu, Chuang-Chun
    [J]. AFRICAN JOURNAL OF BUSINESS MANAGEMENT, 2010, 4 (14): : 3026 - 3038
  • [3] R&D MANAGEMENT OF JAPANESE PHARMACEUTICAL FIRMS
    Mahlich, Jorg
    [J]. INTERNATIONAL JOURNAL OF INNOVATION AND TECHNOLOGY MANAGEMENT, 2011, 8 (02) : 211 - 226
  • [4] Management for R&D in Pharmaceutical Supply Chains
    Huang Yin
    Li Xiamiao
    Liu Dapeng
    [J]. MOT2009: PROCEEDINGS OF ZHENGZHOU CONFERENCE ON MANAGEMENT OF TECHNOLOGY, VOLS I AND II, 2009, : 638 - 644
  • [5] Ownership of knowledge - the role of patents in pharmaceutical R&D
    Correa, CM
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2004, 82 (10) : 784 - 787
  • [6] An integrative framework for R&D management in system industries
    Vadlamani, BL
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY MANAGEMENT, 1997, 13 (7-8) : 818 - 832
  • [7] The present and future of project management in pharmaceutical R&D
    Schuhmacher, Alexander
    Gassmann, Oliver
    Hinder, Markus
    Kuss, Michael
    [J]. DRUG DISCOVERY TODAY, 2021, 26 (01) : 1 - 4
  • [8] Pharmaceutical R&D Project Management under Risk
    Huang, Yin
    Li, Xiamiao
    Liu, Dapeng
    [J]. PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON RISK MANAGEMENT & GLOBAL E-BUSINESS, VOLS I AND II, 2009, : 854 - 858
  • [9] Knowledge transfer and R&D in pharmaceutical companies: A case study
    Schweizer, L
    [J]. JOURNAL OF ENGINEERING AND TECHNOLOGY MANAGEMENT, 2005, 22 (04) : 315 - 331
  • [10] Knowledge production and commercialization from R&D: the pharmaceutical sector
    Garcia-Valderrama, Teresa
    Sanchez-Ortiz, Jaime
    Mulero-Mendigorri, Eva
    [J]. MANAGEMENT DECISION, 2023, 61 (13) : 222 - 247